High Street Prices of Syringes Correlate with Strict Syringe Possession Laws

REFERENCES

• Butynski W., Reda J. L., Canova D., et al. State Resources and Services Related to Alcohol and Other Drug Abuse Problems: Fiscal Year 1990. National Association of State Alcohol and Drug Abuse Directors, Washington, D.C. 1991
   Google Scholar
• Holmberg S. D. The estimated prevalence and incidence of HIV in 96 large U.S. metropolitan areas. Am. J. Public Health 1996; 86: 642–54
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention, AIDS associated with injecting-drug use—United States 1995. MMWR Morb. Mortal. Wkly. Rep. 1996; 45: 392–398
   PubMedGoogle Scholar
• Kemp R., Miller J., Lungley S., et al. Injecting behaviors and prevalence of hepatitis B, C, and D markers in New Zealand injecting drug user populations. N. Z. Med. J. February 27, 1998; 111(1060)50–53
   PubMed Web of Science ®Google Scholar
• Freeman R. C., Rodriguez G. M., French J. F. Seroprevalence and risk factors associated with HTLV I/II infection in injection drug users in northern New Jersey. J. Addict. Dis. 1995; 14(3)51–66
   PubMed Web of Science ®Google Scholar
• Vlahov D., Khabbaz R. F., Cohn S., et al. Incidence and risk factors for human T-lymphotropic virus type II (HTLV-II) seroconversion among injecting drug users in Baltimore, Maryland. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995; 9: 89–96
   PubMedGoogle Scholar
• Heimer R., Khoshnood K., Jariwalafreeman B., et al. Hepatitis in used syringes—the limits of sensitivity of techniques to detect hepatitis B virus (HBV) DNA, hepatitis C virus (HCV) RNA, and antibodies to HBV core and HCV antigens. J. Infect. Dis. 1996; 173: 997–1000
   PubMed Web of Science ®Google Scholar
• Lurie P., Reingold A. L., Bowser B., et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. University of California, San Francisco 1993
   Google Scholar
• Paone D., Des Jarlais D. C., Clark J., et al. Syringe exchange programs—United States, 1994–1995. MMWR Morb. Mortal. Wkly. Rep. 1995; 44: 684–685
   PubMedGoogle Scholar
• Bigg D. Untitled [letter]. Int. J. Drug Policy 1995; 6: 292
   Google Scholar
• Gostin L. O. The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998; 18(1)S60–S70
   Google Scholar
• Gleghorn A. A., Wright-De Aguero L., Flynn C. Feasibility of one-time use of sterile syringes: a study of active injection drug users in seven United States metropolitan areas. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998; 18(1)S30–S36
   Google Scholar
• Guydish J., Bucardo J., Clark G., et al. Evaluating needle exchange: a description of client characteristics, health status, program utilization, and HIV risk behavior, Subst. Use Misuse. April 1998; 33(5)1173–1196
   Google Scholar
• Koester S. K. Copping, running, and paraphernalia laws: contextual variables and needle risk behavior among injection drug users in Denver. Hum. Organ 1994; 53: 287–295
   Web of Science ®Google Scholar
• Gossop M., Griffiths P., Powis B., et al. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment. AIDS Care 1993; 2(5)159–168
   Web of Science ®Google Scholar
• Gostin L. O., Lazzarini Z., Jones T. S., et al. Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. JAMA 1997; 277(1)53–62
   PubMed Web of Science ®Google Scholar
• Stata Corporation STATA. Author, College Station, Texas 1984–1997
   Google Scholar
• Rich J. D., Dickinson B. P., Liu K., et al. Strict syringes laws in Rhode Island are associated with high rates of reusing syringes and HIV risks among injection drug users. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1998; 18(suppl 1)S140–S141
   Google Scholar
• Preventing HIV Transmission: The Role of Sterile Needles and Bleach, J. Normand, D. Vlahov, L. E. Moses. National Academy Press, Washington, D.C. 1995
   Google Scholar
• Lurie P., Reingold A. L., Bowser B., et al. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. University of California, Institute for Health Policy Studies, San Francisco 1993; 1
   Google Scholar
• Des Jarlais D. C., Friedman S. R., Hopkins W. Risk reduction for the acquired immuno-deficiency syndrome among intravenous drug users. Ann. Int. Med. 1985; 103: 755–759
   PubMed Web of Science ®Google Scholar
• Groseclose S. L., Weinstein B., Jones T. S., et al. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992–1993. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1995; 10: 82–89
   PubMedGoogle Scholar
• U.S. Public Health Service. HIV Prevention Bulletin: Medical Advice for Persons Who Inject Illicit Drugs. Centers for Disease Control and Prevention, Atlanta, Georgia May 9, 1997
   Google Scholar
• Des Jarlais D. C., Hagan H., Friedman S. R., et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995; 274: 1226–1231
   PubMed Web of Science ®Google Scholar